PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS UNDERGOING ERCP ARE AT INCREASED RISK FOR PANCREATITIS: RECTAL INDOMETHACIN SIGNIFICANTLY REDUCES THE RISK

被引：0
|
作者：
Thiruvengadam, Nikhil
Forde, Kimberly A.
Chandrasekhara, Vinay
Kochman, Michael L.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30597-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
292
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance
    Ehlken, Hanno
    Zenouzi, Roman
    Schramm, Christoph
    CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (02) : 78 - 84
  • [42] Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis
    Ludvigsson, Jonas F.
    Bergquist, Annika
    Montgomery, Scott M.
    Bahmanyar, Shahram
    JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 802 - 808
  • [43] Increased Risk of Colorectal Cancer and Dysplasia in Patients With Crohn's Colitis and Primary Sclerosing Cholangitis
    Lindstrom, Lina
    Lapidus, Annika
    Ost, Ake
    Bergquist, Annika
    DISEASES OF THE COLON & RECTUM, 2011, 54 (11) : 1392 - 1397
  • [44] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients
    Kamal, Ayesha
    Akshintala, Venkata
    Talukdar, Rupjyoti
    Goenka, Mahesh K.
    Kochhar, Rakesh
    Sinha, Saroj
    Goud, Rajesh
    Kumar, Vijay
    Elmunzer, B. Joseph
    Khashab, Mouen
    Kalloo, Anthony N.
    Reddy, Duvvur Nageshwar
    Singh, Vikesh K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S429 - S429
  • [45] PROGNOSTIC IMPACT OF ERCP FOR ASYMPTOMATIC PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Horio, Ryosuke
    Kato, Jun
    Oyama, Yuhei
    Nakazawa, Hayato
    Mamiya, Yukiyo
    Goto, Chihiro
    Takahashi, Satsuki
    Kurosugi, Akane
    Shiratori, Wataru
    Kaneko, Tatsuya
    Akizue, Naoki
    Ohta, Yuki
    Taida, Takashi
    Okimoto, Kenichiro
    Saito, Keiko
    Matsumura, Tomoaki
    Kato, Naoya
    GASTROENTEROLOGY, 2023, 164 (06) : S1210 - S1210
  • [46] ERCP associated complications in patients with primary sclerosing cholangitis.
    Eng, SC
    Lee, SD
    Kimmey, MB
    Tung, BY
    Saunders, MD
    Kowdley, KV
    HEPATOLOGY, 2001, 34 (04) : 524A - 524A
  • [47] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients
    Kamal, Ayesha
    Akshintala, Venkata
    Talukdar, Rupjyoti
    Goenka, Mahesh K.
    Kochhar, Rakesh
    Sinha, Saroj
    Goud, Rajesh
    Kumar, Vijay
    Elmunzer, B. Joseph
    Khashab, Mouen
    Kalloo, Anthony N.
    Reddy, Duvvur Nageshwar
    Singh, Vikesh K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S429 - S430
  • [48] APPENDECTOMY IS ASSOCIATED WITH AN INCREASED RISK OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    Sifuentes, Humberto
    Sridhar, Subbaramiah
    GASTROENTEROLOGY, 2018, 154 (06) : S1208 - S1208
  • [49] Biliary dysplasia in primary sclerosing cholangitis as a marker of increased risk of cholangiocarcinoma.
    Fleming, KA
    Clausen, OP
    Glauman, H
    Bergquist, A
    Smith, D
    HEPATOLOGY, 1998, 28 (04) : 446A - 446A
  • [50] RECTAL INDOMETHACIN DECREASE THE RISK OF POST-ERCP PANCREATITIS IN CONSECUTIVE PATIENTS. A TERTIARY REFERRAL CENTER EXPERIENCE
    Abdelfatah, Mohamed M.
    Koutlas, Nicholas
    Gochanour, Eric
    Hamed, Ahmad
    Othman, Mohamed O.
    GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB584 - AB584
12345